<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.managedhealthcareexecutive.com/view/for-transgender-women-with-hiv-risk-awareness-and-provider-trust-shape-anal-cancer-follow-up</loc>
      <lastmod>2026-11-20T19:54:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T19:54:00Z</news:publication_date>
        <news:title><![CDATA[For transgender women with HIV, risk awareness and provider trust shape anal cancer follow-up]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/dme-cost-analysis-results-fewer-injections-drive-lower-total-costs</loc>
      <lastmod>2026-11-20T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T13:05:00Z</news:publication_date>
        <news:title><![CDATA[DME Cost Analysis Results: Fewer Injections Drive Lower Total Costs]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/dme-cost-analysis-strengths-and-limits-of-trial-based-economic-modeling</loc>
      <lastmod>2026-11-20T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T13:00:00Z</news:publication_date>
        <news:title><![CDATA[DME Cost Analysis: Strengths and Limits of Trial-Based Economic Modeling]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/closing-rural-maternity-care-gaps-starts-close-to-home-centene-and-aafp-leaders-say</loc>
      <lastmod>2026-11-19T22:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Closing rural maternity care gaps starts close to home, Centene and AAFP leaders say]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/the-role-of-janus-kinase-inhibitors</loc>
      <lastmod>2026-11-19T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:05:00Z</news:publication_date>
        <news:title><![CDATA[The role of Janus kinase inhibitors]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/the-role-of-biologics-in-the-management-of-hidradenitis-suppurativa</loc>
      <lastmod>2026-11-19T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:00:00Z</news:publication_date>
        <news:title><![CDATA[The role of biologics in the management of hidradenitis suppurativa]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.managedhealthcareexecutive.com/view/nelkarmi-gives-alk-positive-lung-cancer-patients-a-new-option-after-first-line-therapy-stops-working</loc>
      <lastmod>2026-11-18T21:53:46.791Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Managed Healthcare Executive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:53:46.791Z</news:publication_date>
        <news:title><![CDATA[Nelkarmi gives ALK-positive lung cancer patients a new option after first-line therapy stops working]]></news:title>
      </news:news>
	</url></urlset>